Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Among Adolescent and Young Adult Females in the United States
| Sponsor: |
National Institute of Allergy and Infectious Diseases |
| Enrolling: |
Female Patients Only |
| Study Length: |
12 Months |
| Clinic Visits: |
7 |
| IRB Number: |
ACYY1351 |
| Contact: |
Kamesha Martin: 6468918746 / km3668@cumc.columbia.edu |
HPTN 115/Foxxy Doxy is looking at doxycycline, a well-known antibiotic that is commonly used to prevent and treat acne and some sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis. This study is trying to find out if taking doxycycline either after condomless sex (known as on-demand doxyPEP) or weekly doxycycline can reduce STI rates for adolescent and young adult females. Study participants will be randomly assigned to receive: 1) on-demand doxyPEP, 2) weekly doxycycline, or 3) standard of care only. All groups will receive standard of care which includes standard STI testing, treatment, and sexual health counseling. All participants will get a mobile health app with simple tools to record health information such as sexual behavior and use of doxycycline. Participants may receive compensation valued at least $400 for completing all study visits during the 12-month study period. Participants may also earn up to $150 for answering surveys in the mobile health app.
Investigator
Yael Hirsch-Moverman, PhD
| Are you between the age of 13-29? |
Yes |
No |
| Do you weigh at least 100 pounds or more? |
Yes |
No |
| Are you sexually active with male partners? |
Yes |
No |
| Have you had vaginal, anal, or oral sex with a man without a condom in the past 1 month? |
Yes |
No |
| Have you been diagnosed with either syphilis, gonorrhea, and/or chlamydia in the past 12 months? |
Yes |
No |